Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC) Meeting Abstract
| Authors: | Cabanillas, M. E.; Lin, J. J.; Brose, M. S.; McDermott, R. S.; Almubarak, M.; Bauman, J. R.; Casanova, M.; Kummar, S.; Lee, S. H.; Leyvraz, S.; Oh, D. Y.; Shen, L.; Neu, N.; Bernard-Gauthier, V.; Mussi, C. E.; Hong, D. S.; Drilon, A. E.; Waguespack, S. G. |
| Abstract Title: | Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401553 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.6095 |
| Notes: | Meeting Abstract: 6095 -- Source: Wos |
